Xenon Pharmaceuticals (XENE) Shares Issued (2013 - 2026)

Xenon Pharmaceuticals (XENE) has 14 years of Shares Issued data on file, last reported at $5.5 million in Q1 2026.

• Shares Issued for Q1 2026 came in at $5.5 million, up 376.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.3 million (up 676.13% YoY), and the FY2025 annual result was $5.0 million, up 10457.45% from the prior year.
• Shares Issued climbed to $5.5 million in Q1 2026 per XENE's latest filing, from $1.4 million in the prior quarter.
• Over five years, Shares Issued peaked at $29.5 million in Q3 2023 and troughed at -$29.5 million in Q4 2023.
• A 5-year average of $1.8 million and a median of $1.3 million in 2025 frame the typical range for Shares Issued.
• The sharpest annual moves came in 2022 and 2023: Shares Issued jumped 7330.19% in 2022, then plunged 491316.67% in 2023.
• A 5-year view of Shares Issued shows it stood at $6000.0 in 2022, then sank by 491316.67% to -$29.5 million in 2023, then soared by 100.16% to $47000.0 in 2024, then soared by 2848.94% to $1.4 million in 2025, then jumped by 295.89% to $5.5 million in 2026.
• Business Quant data shows XENE's Shares Issued at $5.5 million in Q1 2026, $1.4 million in Q4 2025, and $2.4 million in Q3 2025.